P53 inhibits tumor progression by controlling the composition of microRNAs carried by exosomes and the pattern of cytokine secretion, thereby maintaining the differentiated state of tumor-associated nerves, and inhibiting neutrophil infiltration, respectively (Zhou et al., 2021). The gene discussed is TP53; the disease is neoplasm.